Biohaven Pharmaceutical Holding Company Ltd.
Hedge Funds Holdings
Last updated:
Biohaven Pharmaceutical Holding Company Ltd.‘s stocks are currently a part of 296 hedge funds’ portfolios, which represents 98.17% of the total amount of its stocks outstanding. This makes up a total of 63.49M shares of Biohaven Pharmaceutical Holding Company Ltd.. Compared to the previous quarter, the number grew by 2.37% or 1.47M shares more. As for the holding position changes, 37.84% (112) of current hedge fund investors increased the number of shares held, 35.81% (106) of current holders sold a part of the shares held, and 10.14% (30) closed the holdings completely. 56 hedge funds are new holders of Biohaven Pharmaceutical Holding Company Ltd. stock in Q1 2022, it is 18.92% of total holders.
Hedge funds holding Biohaven Pharmaceutical Holding Company Ltd. (Q2 2017 – Q1 2022)
Q2 2017 | 70 |
---|---|
Q3 2017 | 76 |
Q4 2017 | 89 |
Q1 2018 | 97 |
Q2 2018 | 101 |
Q3 2018 | 115 |
Q4 2018 | 129 |
Q1 2019 | 167 |
Q2 2019 | 193 |
Q3 2019 | 180 |
Q4 2019 | 182 |
Q1 2020 | 169 |
Q2 2020 | 218 |
Q3 2020 | 208 |
Q4 2020 | 231 |
Q1 2021 | 216 |
Q2 2021 | 215 |
Q3 2021 | 238 |
Q4 2021 | 275 |
Q1 2022 | 296 |
Hedge funds changes in Biohaven Pharmaceutical Holding Company Ltd. positions (Q2 2017 – Q1 2022)
Q2 2017 | 70 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q3 2017 | 19 | 31 | 14 | 13 | -1 |
Q4 2017 | 29 | 31 | 14 | 16 | -1 |
Q1 2018 | 22 | 51 | 19 | 14 | -9 |
Q2 2018 | 17 | 36 | 34 | 13 | 1 |
Q3 2018 | 23 | 43 | 37 | 9 | 3 |
Q4 2018 | 34 | 44 | 36 | 20 | -5 |
Q1 2019 | 50 | 59 | 34 | 11 | 13 |
Q2 2019 | 62 | 83 | 39 | 32 | -23 |
Q3 2019 | 33 | 70 | 56 | 44 | -23 |
Q4 2019 | 33 | 62 | 67 | 24 | -4 |
Q1 2020 | 32 | 67 | 47 | 41 | -18 |
Q2 2020 | 65 | 75 | 59 | 15 | 4 |
Q3 2020 | 22 | 85 | 73 | 30 | -2 |
Q4 2020 | 47 | 79 | 87 | 24 | -6 |
Q1 2021 | 33 | 80 | 87 | 46 | -30 |
Q2 2021 | 39 | 86 | 66 | 38 | -14 |
Q3 2021 | 54 | 78 | 82 | 30 | -6 |
Q4 2021 | 69 | 109 | 78 | 31 | -12 |
Q1 2022 | 56 | 112 | 106 | 30 | -8 |
Hedge funds changes in Biohaven Pharmaceutical Holding Company Ltd. stock options (Q2 2017 – Q1 2022)
Q2 2017 | 0 | 0 |
---|---|---|
Q3 2017 | 1,050,000 | 258,000 |
Q4 2017 | 4,242,000 | 872,000 |
Q1 2018 | 72,682,000 | 9,853,000 |
Q2 2018 | 18,443,000 | 3,193,000 |
Q3 2018 | 12,473,000 | 2,035,000 |
Q4 2018 | 14,301,000 | 7,692,000 |
Q1 2019 | 57,229,000 | 24,862,000 |
Q2 2019 | 162,158,000 | 60,419,000 |
Q3 2019 | 178,057,000 | 29,260,000 |
Q4 2019 | 216,069,000 | 48,254,000 |
Q1 2020 | 117,538,000 | 17,137,000 |
Q2 2020 | 160,091,000 | 37,702,000 |
Q3 2020 | 94,957,000 | 45,413,000 |
Q4 2020 | 296,422,000 | 175,593,000 |
Q1 2021 | 69,119,000 | 49,543,000 |
Q2 2021 | 92,863,000 | 79,845,000 |
Q3 2021 | 96,699,000 | 76,222,000 |
Q4 2021 | 131,451,000 | 139,420,000 |
Q1 2022 | 114,974,000 | 93,563,000 |